Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Negrin

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphomaL J Johnston, K E Stockerl-Goldstein, W W Hu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2002
Advancing animal models of neoplasia through in vivo bioluminescence imagingM Edinger, Y-a Cao, Y S Hornig, et al.
Experimental Hematology|December 1, 1993
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cellsI G Schmidt-Wolf, P Lefterova, B A Mehta, et al.
Cancer|March 15, 1995
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphomaN J Chao, H Kastrissios, G D Long, et al.
Blood|May 15, 1994
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN J Chao, J R Schriber, G D Long, et al.
Blood|January 12, 2001
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trialS J Horning, R S Negrin, R T Hoppe, et al.
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Blood|January 15, 1993
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemiaN J Chao, A S Stein, G D Long, et al.
Cancer|June 20, 2001
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignanciesT M Cao, C Kusnierz-Glaz, F Valone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphomaL J Johnston, K E Stockerl-Goldstein, W W Hu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2002
Advancing animal models of neoplasia through in vivo bioluminescence imagingM Edinger, Y-a Cao, Y S Hornig, et al.
Experimental Hematology|December 1, 1993
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cellsI G Schmidt-Wolf, P Lefterova, B A Mehta, et al.
Cancer|March 15, 1995
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphomaN J Chao, H Kastrissios, G D Long, et al.
Blood|May 15, 1994
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN J Chao, J R Schriber, G D Long, et al.
Blood|January 12, 2001
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trialS J Horning, R S Negrin, R T Hoppe, et al.
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Blood|January 15, 1993
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemiaN J Chao, A S Stein, G D Long, et al.
Cancer|June 20, 2001
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignanciesT M Cao, C Kusnierz-Glaz, F Valone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Pageof 10